MedPath

Probiotics Pilot Project

Not Applicable
Conditions
Staphylococcus Aureus
Interventions
Other: Placebo
Dietary Supplement: Bacillus subtilis probiotic
Registration Number
NCT04247854
Lead Sponsor
Rothman Institute Orthopaedics
Brief Summary

This pilot study is designed to determine if ingestion of Bacillus probiotics can cause alteration in levels of S. aureus colonization in the nose and intestine in preoperative orthopedic patients undergoing elective primary TJA.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Not specified
Target Recruitment
20
Inclusion Criteria
  1. Adults (age >18 years)
  2. Undergoing elective primary knee or hip arthroplasty
  3. Confirmed colonization of nares and/or rectum with S. aureus or MRSA on routine standard-of-care preadmission testing
  4. Written informed consent
Exclusion Criteria
  1. Regular use of a probiotic or prebiotic supplement within 3 months prior to enrollment
  2. Antibiotic use within 3 months prior to enrollment
  3. Active clinical infection
  4. Participation in other clinical trials
  5. Presence of pregnancy or lactation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
No interventionPlacebo-
ProbioticBacillus subtilis probiotic-
Primary Outcome Measures
NameTimeMethod
Persistent Staphylococcus aureus colonizationpost-intervention: following 5 days of dietary supplementation
Secondary Outcome Measures
NameTimeMethod
Changes in microbiome compositionpost-intervention: following 5 days of dietary supplementation

as determine through next generation sequencing of samples collect from the patient

Trial Locations

Locations (1)

Rothman Institute

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath